Despite aggressive, early and continuous growth hormone (GH) treatment of children with idiopathic (I) growth hormone deficiency (GHD), height outcomes are often below -1 SDS and do not achieve mid-parental height targets. As pubertal growth accounts for
A brief review of the addition of gonadotropin-releasing hormone agonists (GnRH-Ag) to growth hormone (GH) treatment of children with idiopathic growth hormone deficiency: Previously published studies from America.All Scholarly Works
Document TypeArticle, Peer-reviewed
Citation InformationMol Cell Endocrinol. 2006 Jul 25;254-255:221-5. Epub 2006 Jun 19.